Efficacy of trilostane for the treatment of equine Cushing's syndrome

REASONS FOR PERFORMING STUDY: Trilostane, a competitive 3-beta hydroxysteroid dehydrogenase inhibitor, has been used successfully to control clinical signs and cortisol excess in canine pituitary dependent hyperadrenocorticism. OBJECTIVES: Trilostane was evaluated for its efficacy in resolving clinical and clinicopathological abnormalities of equine Cushing's syndrome (ECS) and to assess its safety. METHODS: Twenty horses (mean age 21 years) diagnosed with ECS were followed for 1 or 2 years. Affected horses received 0.4-1 mg/kg (mean 0.5 mg/kg) trilostane once daily. RESULTS: Clinical signs assessed over 1 or 2 years, showed a reduction in lethargy in all horses post treatment. Polyuria and/or polydipsia, present in 11 horses, was reduced in all after treatment. Recurrent or chronic laminitis, present in 16 horses, improved in 13/16 (81%) of cases. There were no side effects reported. Combined dexamethasone suppression and thyrotropin releasing hormone (TRH) stimulation tests were significantly different before and 30 days following therapy. There was a significant reduction (P = 0.01) of cortisol following TRH administration before (160 +/- 53.0 nmol/l) and after (130 +/- 46.1 nmol/l) trilostane. CONCLUSIONS: Trilostane caused improvement in clinical signs in horses, without side effects, and a corresponding decrease in cortisol response to TRH administration. POTENTIAL RELEVANCE: Trilostane may be a useful therapy for the treatment of ECS. Further work comparing the effects of trilostane and pergolide is warranted.     

Incidence of exertional rhabdomyolysis in polo horses in the USA and the United Kingdom in the 1999/2000 season

A questionnaire was used to determine the incidence of exertional rhabdomyolysis and the factors that might have contributed to its occurrence among 423 polo horses in 11 yards. The yards were selected at random, six of them with 111 horses, in north-eastern USA, and five with 312 horses in south-east England. During the 1999/2000 season the incidence of the condition was 7.3 per cent (9 per cent in the USA and 6.7 per cent in England). The incidence in mares was similar in the two countries, 8.4 per cent in the USA and 8.0 per cent in England, but the incidence in geldings in the USA (10 per cent) was much higher than in England (1.5 per cent). A more excitable than average temperament was reported in 71 per cent of the horses with the condition, and most cases occurred after a game (chukka) in which the horse was perceived to be not fit enough for the level of play demanded. Sixty-four per cent of the cases occurred early in the season and on average each episode resulted in the loss of 7.6 training days.     

Epididymitis in rams: effect of vaccination and culling on the clinical incidence of the disease.

Ram epidiymitis caused by Brucella ovis can be effective controlled by an annual program combining rigorous culling clinically affected animals and appropriate vaccination of the remaining animals. Yearling rams purchased or saved as replacement breeders should be immunized at 4-5 months of age by two injections of Br. ovis bacterin spaced 3-6 weeks apart. Annually, approximately one month prior to the breeding season, all rams, replacements and older breeders as well, should be carefully examined by palpation of the scrotal contents. Every ram evidencing an abnormality should be culled as a breeder. All the remaining rams should receive a "booster" injection of Br. ovis bacterin.     

A comparison of the effects of parenteral and oral administration of supplementary vitamin E on plasma vitamin E concentrations in dairy cows at different stages of lactation

As a result of research conducted in the US, recommendations for dry cow vitamin E intakes have increased seven fold there, however there has been no change to recommendations in the UK. As part of a larger study comparing the impact of existing UK and new US recommended vitamin E intakes on the health and fertility of commercial dairy cows in the UK, a study was set up to investigate the effect of route of supplementation and stage of lactation, over a 21 day period, on the response to mega-supplementation of cattle receiving supposedly adequate vitamin E. The study assessed the response of dry, peak lactation and mid lactation cows to in-feed or parenteral vitamin E supplementation (7 animals per treatment/lactation stage group) by measuring plasma and milk vitamin E concentrations, blood glutathione peroxidase (GSH-Px) activity and milk yields over a 21 day period. Plasma vitamin E concentrations were significantly influenced by a time, stage and treatment interaction (P = 0.046). Both dry and lactating animals had significantly higher plasma vitamin E concentrations at some time points in the parenteral supplemented cows compared to the in-feed supplementated animals (P ≤ 0.011 and P < 0.01, respectively). Milk vitamin E concentrations did not significantly differ between lactation stages but treatment had a significant effect on concentrations (P < 0.008) when lactation stage was removed from the model. There was no significant difference in milk yield between treatment groups. A significant relationship between plasma and milk vitamin E concentrations was only found in the parenterally supplemented cows (r = 0.435, P < 0.001). In cattle with intakes greater than the ARC recommendations, measurement of plasma vitamin E concentration may be of limited value in determining whether there has been a response to supplementation. The relationship between plasma and milk vitamin E concentrations is too poor for milk vitamin E concentrations to be used as a proxy for plasma vitamin E.     

Unusual pathophysiological mechanisms of ptyalism in two horses

This report outlines two cases of ptyalism that were not associated with oral conditions or primary dysphagia. The first, a 9-year-old Thoroughbred gelding, was associated with left-sided peripheral vestibular disease and bone modelling around the left tympanic bulla. The second, a 7-year-old Dutch Warmblood mare, was associated with progressive bilateral laryngeal paralysis and a mediastinal T-cell lymphoma. In Case 1, a neurological pathophysiology was proposed involving altered autonomic innervation of the salivary glands; whilst in Case 2, the mechanism remains unclear but may have involved mechanical compression of the intrathoracic oesophagus or stimulation of afferents within the vagus nerve. This case series highlights rare causes of ptyalism that have not been previously reported in the literature.     

What does IUCN species action planning contribute to the conservation process?

More than 60 Species Action Plans have been published by the Species Survival Commission (SSC) of IUCN—The World Conservation Union. They are designed to assess the status of threatened species and their habitats, and provide prioritised recommendations for action, but there is debate about the effectiveness of such plans in stimulating conservation action and research. We evaluated three Action Plans covering a group of large terrestrial birds, published in 1995. Of 54 projects suggested in these plans, 33 had been initiated in the 5 years since publication, and 35 specific conservation actions were undertaken. Forty-five peer-reviewed papers were published, and at least 88 other outputs in the form of symposium presentations, posters and popular articles were produced. Although it is impossible to demonstrate the effectiveness of species action planning through rigorous scientific assessment, these results indicate a substantial amount of conservation-relevant activity directly attributable to the process. They also highlight the need for a clear definition of the role of Action Plans. We suggest that many of the criticisms directed toward species action plans result from an over-optimistic view of their power to catalyse action, and conclude by presenting a new model describing their niche within the wider context of conservation biology and policy.